secwatch.observer — SEC 8-K summary
======================================

Issuer:     Matinas BioPharma Holdings, Inc. (MTNB)
CIK:        0001582554
Form:       8-K
Filed at:   2024-03-28T23:59:59+00:00
Accession:  0001493152-24-011625
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Matinas BioPharma updates corporate presentation; no material new information disclosed
--------------------------------------------------------------------------------

- Furnished updated corporate presentation dated March 28, 2024 under Regulation FD.
- Presentation to be used at conferences and investor meetings; specific content not provided.
- No financial results, guidance, or operational milestones disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582554/000149315224011625/0001493152-24-011625-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582554/000149315224011625/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-011625

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer